6533b7d2fe1ef96bd125ec97
RESEARCH PRODUCT
Prevalence of Toscana and Sicilian Phlebovirus Antibodies in Classic Kaposi Sarcoma Case Patients and Control Subjects in Sicily
Gianni Gori-savelliniMaria Grazia CusiMelissa ValentiniEmanuele AmodioNino RomanoRosalia Maria ValentiJames J. Goedertsubject
MalePhlebovirusphlebovirus classic Kaposi sarcoma SicilyComorbidityBiologyAntibodies ViralSettore MED/42 - Igiene Generale E ApplicataImmunoglobulin GVirusMajor Articles and Brief ReportsSeroepidemiologic StudiesHumansImmunology and AllergySeroprevalenceSarcoma KaposiAgedAged 80 and overClassic Kaposi SarcomaOdds ratioMiddle Agedbiology.organism_classificationVirologyInfectious DiseasesImmunoglobulin MItalyPhlebovirusImmunoglobulin MImmunoglobulin GHerpesvirus 8 HumanImmunologybiology.proteinFemaleAntibodydescription
To assess whether arthropod bites promote Kaposi sarcoma (KS), we determined the seroprevalence of Sicilian (SFSV) and Toscana (TOSV) phlebovirus antibodies in 30 patients with classic KS and 100 controls in Sicily. Nine (6.9%) subjects, all controls, were positive for SFSV, whereas 41 (31.5%) were positive for TOSV. Seroprevalence with immunoglobulin (Ig) M or IgG against either virus was significantly higher in controls (43% vs 13.3% in case patients; P < .01). Adjusted for age, IgG seroprevalence was significantly lower in KS patients compared to controls (adjusted odds ratio, 0.22; 95% confidence interval, .07–.72). Low phlebovirus seroprevalence in patients with KS may reflect incapacity to produce robust, persistent antibody responses, and suggests that arthropod bites do not promote KS.
| year | journal | country | edition | language |
|---|---|---|---|---|
| 2011-11-01 | The Journal of Infectious Diseases |